Skip to content
Search

Latest Stories

Government commits to protect public health policy from tobacco industry interference

The government is committed to protect public health policy from the interference of the tobacco industry, Public Health minister Jo Churchill told the Parliament on Thursday night.

The minister’s statement follows recent revelations that a leading tobacco manufacturer has attempted to subvert the UK Government’s tobacco policy.


During an adjournment debate on the topic, Bob Blackman MP, who is the Chairman of All Party Group on Smoking and Health, asked the minister to reaffirm the government’s commitment to the UK’s obligation to Article 5.3 of the WHO Framework Convention on Tobacco Control and its guidelines.

“In answer to my honourable friend’s direct question we will absolutely remain firmly committed to the Convention and importantly Article 5.3 during the transition period and beyond,” the minister said in response.

The article urges the countries to protect public health policies regarding tobacco control from the commercial and vested interests of tobacco companies in terms of formulation and implementation of these policies.

“I am very proud that in the first Global Tobacco Industry Interference Index published last year we were rated number one for the work that we do to protect public health policy from tobacco companies, but I take on board that we need to continue on that path,” she added.

The minister also confirmed that the government’s response to the Prevention Green Paper consultation will be published shortly.

Bob Blackman MP said: “In the Prevention Green paper the Government promised to consider how tobacco manufacturers could be made to fund tobacco control measures, in line with the polluter pays approach in place in the US. This would raise a fixed sum from tobacco manufacturers, without in return giving them a seat at the table to influence tobacco policy.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less